1 The modulatory eects of protein kinase C (PKC) on the activation of cytosolic phospholipase A 2 (cPLA 2 ) and adenylyl cyclase (AC) have recently been described. Since the signalling cascades associated with these events play critical roles in various functions of macrophages, we set out to investigate the crosstalk between PKC and the cPLA 2 and AC pathways in mouse RAW 264.7 macrophages and to determine the involvement of individual PKC isoforms. The cPLA 2 and AC pathways were studied by measuring the potentiation by the phorbol ester PMA of ionomycin-induced arachidonic acid (AA) release and prostagladin E 1 (PGE 1 )-stimulated cyclic AMP production, respectively. 2 PMA at 1 mM caused a signi®cant increase in AA release both in the presence (371%) and absence (67%) of ionomycin induction, while exposure of RAW 264.7 cells to PMA increased PGE 1 stimulation of cyclic AMP levels by 208%. 3 Treatment of cells with staurosporine and Ro 31-8220 inhibited the PMA-induced potentiation of both AA release and cyclic AMP accumulation, while Go 6976 (an inhibitor of classical PKC isoforms) and LY 379196 (a speci®c inhibitor of PKCb) inhibited the AA response but failed to aect the enhancement of the cyclic AMP response by PMA. 4 Long term pretreatment of cells with PMA abolished the subsequent eect of PMA in potentiating AA release, but only inhibited the cyclic AMP response by 42%. 5 Neither PD 98059, an inhibitor of MEK, nor genistein, an inhibitor of tyrosine kinases, had any eect on the ability of PMA to potentiate AA or cyclic AMP production. 6 The potentiation of AA release, but not of cyclic AMP formation, by PMA was sensitive to inhibition by wortmannin. This eect was unrelated to the inhibition of PKC activation as deduced from the translocation of PKC activity to the cell membrane. 7 Western blot analysis revealed the presence of eight PKC isoforms (a, bI, bII, d, e, m l and x) in RAW 264.7 cells and PMA was shown to induce the translocation of the a, bI, bII, d, e and m isoforms from the cytosol to the cell membrane within 2 min. 8 Pretreatment of cells with PMA for 2 ± 24 h resulted in a time-dependent down-regulation of PKCa, bI, bII, and d expression, while the levels of the other four PKC isozymes were unchanged after PMA treatment for 24 h. A decrease in the potentiation of AA release by PMA was observed, concomitant with the time-dependent down-regulation of PKC. 9 These results indicate that PKCb has a crucial role in the mediation of cPLA 2 activation by the phorbol ester PMA, whereas PMA utilizes PKC e and/or m to up-regulate AC activity.
